Document Detail


Toxicological considerations for antithyroid drugs in children.
MedLine Citation:
PMID:  21323607     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Propylthiouracil (PTU), methimazole (MMI) and carbimazole are indicated for the treatment of hyperthyroidism in adult and pediatric patients. The aim of this review is to present all the relevant information regarding the use of antithyroid drugs (ATD) in pediatric thyrotoxic cases, the pediatric toxicology of ATD and the warning which has recently been issued for PTU by the FDA.
AREAS COVERED: Epidemiology, diagnosis and treatment of pediatric thyrotoxicosis are all presented in this article. The authors also extensively discuss the details regarding the pharmacology, bioactivation, biodisposition, bioavailability and pharmacokinetic properties of the two main ATD (MMI and PTU).
EXPERT OPINION: The FDA recently reported that use of PTU is associated with a higher risk for clinically serious or fatal liver injury compared to MMI in both adult and pediatric patients. They also found that congenital malformations were reported approximately three times more often with prenatal exposure to MMI compared with PTU and especially with the use of MMI during the first trimester of pregnancy. The authors believe that PTU should not be used in pediatric patients unless the patient is allergic to or intolerant of MMI, and there are no other treatment options available. That being said, PTU may be the treatment of choice during, and just before, the first trimester of pregnancy.
Authors:
Spiros Karras; Themistoklis Tzotzas; Gerasimos E Krassas
Related Documents :
8919517 - Changes in skin ph after the use of baby wipes.
21196307 - The state of the art of in vitro fertilization.
24963187 - Caesarean section in a case of systemic lupus erythematosus.
21323607 - Toxicological considerations for antithyroid drugs in children.
21112617 - Prenatal animal contact and gene expression of innate immunity receptors at birth are a...
24327997 - The frequency and clinical significance of intra-amniotic inflammation defined as an el...
Publication Detail:
Type:  Journal Article; Review     Date:  2011-02-17
Journal Detail:
Title:  Expert opinion on drug metabolism & toxicology     Volume:  7     ISSN:  1744-7607     ISO Abbreviation:  Expert Opin Drug Metab Toxicol     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-22     Completed Date:  2011-07-07     Revised Date:  2013-11-06    
Medline Journal Info:
Nlm Unique ID:  101228422     Medline TA:  Expert Opin Drug Metab Toxicol     Country:  England    
Other Details:
Languages:  eng     Pagination:  399-410     Citation Subset:  IM    
Affiliation:
Panagia General Hospital, Department of Endocrinology, Diabetes and Metabolism, N. Plastira, 22, N. Krini 55132, Thessaloniki, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Agranulocytosis / complications
Animals
Antithyroid Agents / therapeutic use,  toxicity*
Carbimazole / therapeutic use,  toxicity*
Child
Child, Preschool
Evidence-Based Medicine
Female
Graves Disease / drug therapy
Humans
Hyperthyroidism / drug therapy
Liver Failure / complications
Methimazole / therapeutic use,  toxicity*
Pregnancy
Propylthiouracil / therapeutic use,  toxicity*
Randomized Controlled Trials as Topic
Thyrotoxicosis / drug therapy
Vasculitis / complications
Chemical
Reg. No./Substance:
0/Antithyroid Agents; 22232-54-8/Carbimazole; 51-52-5/Propylthiouracil; 60-56-0/Methimazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Liposomal solubilization of new 3-hydroxy-quinolinone derivatives with promising anticancer activity...
Next Document:  Antiarrhythmic drugs for atrial fibrillation.